| Ralph Schmeltz, MD | |
|
86 Wellness Way, Washington, PA 15301-9720 | |
| (724) 229-3300 | |
| (724) 229-0975 |
| Full Name | Ralph Schmeltz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 86 Wellness Way, Washington, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053381640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD010398E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ralph Schmeltz, MD 86 Wellness Way, Washington, PA 15301-9720 Ph: (724) 229-3300 | Ralph Schmeltz, MD 86 Wellness Way, Washington, PA 15301-9720 Ph: (724) 229-3300 |
News Archive
Hierarchies exist across all human and animal societies, organized by what behavioral scientists refer to as dominance. Dominant individuals tend to climb higher up the hierarchy ladder of their particular society, earning priority access to resources.
Researchers from Princeton University have identified genes important for age-related cognitive declines in memory in adult worm neurons, which had not been studied previously. The research, published in the journal Nature, could eventually point the way toward therapies to extend life and enhance health in aging human populations.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, together with collaborators at the Massachusetts Institute of Technology (MIT), announced today the publication of new paper describing discovery of "core-shell" nanoparticles for systemic delivery of RNAi therapeutics.
"We are pleased to receive positive CHMP opinions for Kyprolis and BLINCYTO as this is an important step in providing new treatment options for patients in Europe with rare forms of cancer," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen.
According to Dr. Daniel Weiss, a recent study of heart rate autonomic markers, and cardiac mortality published in the November issue of Heart Rhythm provides additional support for the usefulness of heart rate variability as a diagnostic for identifying dysfunction (neuropathy in diabetics and others) and cardiovascular mortality, including fatal arrhythmia or sudden cardiac death.
› Verified 9 days ago
Nitin Kapoor, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 470 Johnson Rd, Suite 10, Washington, PA 15301 Phone: 724-223-3816 | |
Dr. Jose Vicente Venero, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 125 N Franklin Dr, Washington, PA 15301 Phone: 724-225-6500 Fax: 724-229-2170 | |
Dr. Brian Albert Staub, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 125 N Franklin Dr, Suite 1, Washington, PA 15301 Phone: 724-225-6500 | |
Richard Hart, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1000 Park Place, Ste 209, Washington, PA 15301 Phone: 724-229-7570 Fax: 724-229-7571 | |
Sun Scolieri, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 125 N Franklin Dr Ste 1, Washington, PA 15301 Phone: 724-225-6500 Fax: 724-229-2170 | |
Dr. Catheri J. Brennan, CATHERINE J. BRENNAN Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 100 Ridge Ave, Washington, PA 15301 Phone: 724-250-7790 |